These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9437405)

  • 21. Association of low plasma high density lipoprotein (HDL)-cholesterol concentration with documented coronary artery disease in males with non-insulin dependent diabetes mellitus.
    Fuh MM; Shieh SM
    Horm Metab Res; 1987 Jun; 19(6):267-70. PubMed ID: 3623416
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevated lipoprotein (a) levels are associated with the presence and severity of coronary artery disease in patients with type 2 diabetes mellitus.
    Zhang HW; Zhao X; Guo YL; Gao Y; Zhu CG; Wu NQ; Li JJ
    Nutr Metab Cardiovasc Dis; 2018 Oct; 28(10):980-986. PubMed ID: 30030022
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urinary excretion of apo(a) fragments in NIDDM patients.
    Clodi M; Oberbauer R; Waldhäusl W; Maurer G; Kostner GM; Kostner K
    Diabetologia; 1997 Dec; 40(12):1455-60. PubMed ID: 9447954
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipoprotein (a) and other risk factors in children with insulin-dependent diabetes mellitus and children without diabetes.
    Martinez MT; Ramos O; Carretero N; Calvillán M; Gutierrez-López MD; Cuesta P; Serrano-Ríos M
    Diabete Metab; 1994; 20(5):454-7. PubMed ID: 7859892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of low-density lipoprotein particle size distribution in NIDDM and coronary disease: importance of serum triglycerides.
    Lahdenperä S; Syvänne M; Kahri J; Taskinen MR
    Diabetologia; 1996 Apr; 39(4):453-61. PubMed ID: 8777995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin resistance and arteriosclerosis obliterans in patients with NIDDM.
    Matsumoto K; Miyake S; Yano M; Ueki Y; Yamaguchi Y; Akazawa S; Tominaga Y
    Diabetes Care; 1997 Nov; 20(11):1738-43. PubMed ID: 9353618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of insulin treatment on serum lipoprotein(a) in non-insulin-dependent diabetes.
    Kuusi T; Yki-Järvinen H; Kauppinen-Mäkelin R; Jauhiainen M; Ehnholm C; Kauppila M; Seppälä P; Viikari J; Kujansuu E; Rajala S
    Eur J Clin Invest; 1995 Mar; 25(3):194-200. PubMed ID: 7781667
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipids and lipoprotein(a) concentrations in Tunisian type 2 diabetic patients; Relationship to glycemic control and coronary heart disease.
    Smaoui M; Hammami S; Chaaba R; Attia N; Hamda KB; Masmoudi AS; Mahjoub S; Bousslama A; Farhat MB; Hammami M
    J Diabetes Complications; 2004; 18(5):258-63. PubMed ID: 15337498
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of elevated lipoprotein(a) levels and coronary heart disease in NIDDM patients. Relationship with apolipoprotein(a) phenotypes.
    Ruiz J; Thillet J; Huby T; James RW; Erlich D; Flandre P; Froguel P; Chapman J; Passa P
    Diabetologia; 1994 Jun; 37(6):585-91. PubMed ID: 7926343
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of lipoprotein(a) levels and apolipoprotein(a) phenotypes with coronary artery disease in Type 2 diabetic patients and in non-diabetic subjects.
    Gazzaruso C; Garzaniti A; Falcone C; Geroldi D; Finardi G; Fratino P
    Diabet Med; 2001 Jul; 18(7):589-94. PubMed ID: 11553191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated Lipoprotein(a) has Incremental Prognostic Value in Type 2 Diabetic Patients with Symptomatic Coronary Artery Disease.
    Kwon SW; Kim JY; Sung JM; Yoon YW; Rhee JH; Lee BK; Jung YH; Kim KH; Cha JJ; Park JK; Choi EY; Hong BK; Rim SJ; Kwon HM
    J Atheroscler Thromb; 2015; 22(5):527-34. PubMed ID: 25445892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peripheral atherosclerosis and serum lipoprotein(a) in diabetes.
    Wollesen F; Dahlén G; Berglund L; Berne C
    Diabetes Care; 1999 Jan; 22(1):93-8. PubMed ID: 10333909
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Different change in lipoprotein(a) levels from lipid levels of other lipoproteins with improved glycemic control in patients with NIDDM.
    Kikuchi T; Onuma T; Shimura M; Tsutsui M; Boku A; Matsui J; Takebe K
    Diabetes Care; 1994 Sep; 17(9):1059-61. PubMed ID: 7988307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Postprandial metabolism of apolipoprotein B-48- and B-100-containing particles in type 2 diabetes mellitus: relations to angiographically verified severity of coronary artery disease.
    Mero N; Malmström R; Steiner G; Taskinen MR; Syvänne M
    Atherosclerosis; 2000 May; 150(1):167-77. PubMed ID: 10781648
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Lipoprotein (a) and non-insulin dependent diabetes mellitus].
    Chi J; Tang W; Sun M
    Zhonghua Nei Ke Za Zhi; 1996 Apr; 35(4):246-8. PubMed ID: 9387640
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical evaluation of plasma high-density lipoprotein subfractions (HDL2, HDL3) in non-insulin-dependent diabetics with coronary artery disease.
    Bakogianni MC; Kalofoutis CA; Skenderi KI; Kalofoutis AT
    J Diabetes Complications; 2001; 15(5):265-9. PubMed ID: 11522502
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipoprotein(a) in South Indian type 2 diabetic subjects in relation to diabetic vascular complications.
    Deepa R; Mohan A; Rema M; Haranath SP; Saravanan G; Mohan V
    J Assoc Physicians India; 2002 May; 50(5):657-61. PubMed ID: 12186119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Abnormalities of low density lipoproteins in normolipidemic type II diabetic and nondiabetic patients with coronary artery disease.
    Tilly-Kiesi M; Syvänne M; Kuusi T; Lahdenperä S; Taskinen MR
    J Lipid Res; 1992 Mar; 33(3):333-42. PubMed ID: 1569383
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum lipids, lipoproteins, and apolipoproteins and the excessive occurrence of coronary heart disease in non-insulin-dependent diabetic patients.
    Rönnemaa T; Laakso M; Kallio V; Pyörälä K; Marniemi J; Puukka P
    Am J Epidemiol; 1989 Oct; 130(4):632-45. PubMed ID: 2773912
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of change of lipoprotein(a) levels by the optimization of glycemic control with insulin therapy in NIDDM patients.
    Caixas A; Pérez A; Qrdóñez-Llanos J; Bonet R; Rigla M; Castellví A; Bayen L; de Leiva A
    Diabetes Care; 1997 Sep; 20(9):1459-61. PubMed ID: 9283797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.